Impulse Dynamics® Completes Enrollment of Pivotal Trial for CCM-D® HF System and Earns Category 1 CPT Codes for CCM® Therapy

Impulse Dynamics® Completes Enrollment of Pivotal Trial for CCM-D® HF System and Earns Category 1 CPT Codes for CCM® Therapy

MARLTON, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Impulse Dynamics®, a global medical device company committed to improving the lives of people with heart failure (HF), announced two major accomplishments, marking an inflection point in the advancement and accessibility of…

Impulse Dynamics’ Pivotal Trial of CCM-D System Completes Enrollment - Cardiac Interventions Today

July 28, 2025—Impulse Dynamics, a developer of cardiac contractility modulation (CCM) technology to treat heart failure (HF), announced completion of enrollment in the INTEGRA-D pivotal trial of its CCM-D HF system. According to the company, the multicenter, prospective, single-arm study is evaluating the safety and efficacy of the CCM-D HF system, which combines Impulse Dynamics’ CCM therapy for the treatment of HF symptoms with implantable car…